Page 2 - செக்மேட் மருந்துகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செக்மேட் மருந்துகள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செக்மேட் மருந்துகள் இன்க் Today - Breaking & Trending Today

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) - The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight

AACR Meeting Presentations
Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI): new translational data from the Phase 1b trial of CMP-001 in subjects with advanced melanoma (Sunday)
Blueprint Medicines Corporation (NASDAQ: BPMC): interim analysis of Phase 2 data for avapritinib in patients with advanced systemic mastocytosis (Sunday)
Mirati Therapeutics, Inc. (NASDAQ: MRTX) and
BeiGene, Ltd. (NASDAQ: BGNE): Phase 1b safety/tolerability and preliminary antitumor activity data for Mirati s sitravatinib plus BeiGene s tislelizumab in patients with advanced platinum-resistant ovarian cancer as well as patients with PD-(L)1 refractory/resistant unresectable or metastatic melanoma (Sunday)
Beigene: results from the Phase 3 study of tislelizumab versus docetaxel as second or third-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (Monday) ....

United States , Eli Lilly , Provention Bio Inc , Gain Therapeutics Inc , Instil Bio Inc , Auris Medical Holding Ltd , Finch Therapeutics Group Inc , Therapeutics Inc , Revance Therapeutics Inc , Pharmaceuticals Inc , Tg Therapeutics Inc , Theratechnologies Inc , Checkmate Pharmaceuticals Inc , Blueprint Medicines Corporation , Fibrogen Inc , Beigene Ltd , American Association Of Cancer Research , Biopharma Holdings Limited , International Society Of Nephrology , Mirati Therapeutics Inc , Chinook Therapeutics Inc , American Academy Of Neurology , Fortress Biotech Inc , World Congress , Cancer Research , Annual Meeting ,

EVP and CFO of Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI), Krieg Arthur M, buys 443 shares worth ,273

EVP and CFO of Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI), Krieg Arthur M, buys 443 shares worth $6,273
According to Checkmate Pharmaceuticals, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 31 04:20 PM, company EVP and CFO, Krieg Arthur M disclosed buying 443 shares at a cost of $14.16. At the time of this transaction (Dec 29), this trade was worth $6,273 in total. As of Dec 29, Krieg Arthur M now owns 730,990 shares in total worth about $10,665,144.1.
For the last few recent trades made by Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) EVP and CFO, Krieg Arthur M, we have the following information: ....

Krieg Arthur , Checkmate Pharmaceuticals Inc , Checkmate Pharmaceuticals , Statement Of Changes In Beneficial Ownership , George Daniels , Friday January , க்ரீக் ஆர்தர் , செக்மேட் மருந்துகள் இன்க் , செக்மேட் மருந்துகள் , அறிக்கை ஆஃப் மாற்றங்கள் இல் நன்மை பயக்கும் ஓநர்‌ஶிப் , ஜார்ஜ் டேனியல்ஸ் , வெள்ளி ஜனவரி ,